Hovedbudskap
Kolinesterasehemmere må betraktes som etablert symptomatisk behandling av Alzheimers sykdom
Memantin er et nytt, lovende legemiddel i behandling av Alzheimers sykdom og vaskulær demens
- 1.
Engedal K. Diagnostikk og behandling av demens Tidsskr Nor Lægeforen 2002; 122: 520 – 4.
- 2.
Qizilbash N. Treatment of Alzheimer’s disease. I: Qizilbash N, Schneider L, Chui H, Tariot P, Brodaty H, Kaye J et al. Evidence-based dementia practice. Oxford: Blackwell Science, 2002: 467 – 588.
- 3.
Winblad B, Poritis N. Memantine in severe dementia: result of the 9M-best study. Int J Geriatr Psychiatry 1999; 14: 135 – 46.
- 4.
Reisberg B, Doody R, Stöffler A et al. Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 2003; 348: 1333 – 41.
- 5.
Areosa Sastre A, Sheriff F. Memantine for dementia (Cochrane review). I: The Cochrane Library, Issue 1, 2003. Oxford: Update Software.
- 6.
Sano M, Ernesto C, Thomas RG et al. A controlled trial of selegeline, alpha-tocopherol, or both as treatment for Alzheimers’s disease. N Engl J Med 1997; 336: 1216 – 22.
- 7.
Ciaconbini E. Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer’s disease. Alzheimer Dis Assoc Disord 2000; 14 (suppl 1): S3-S10.
- 8.
Trinh NH, Hoblyn J, Mohanty S et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer’s disease: a meta-analysis. JAMA 2003; 289: 210 – 6.
- 9.
Feldman H, Gauthier S, Hecker J, and the donepezil MSAD study investigators group. A 24 week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease. Neurology 2001; 57: 613 – 20.
- 10.
McKeith I, Del Ser T, Spano P et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double blind, placebo-controlled international study. Lancet 2000; 356: 2031 – 6.
- 11.
Winblad B, Engedal K, Soininen H et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001; 57: 489 – 95.
- 12.
Black S, Roman GC, Geldmacher DS et al. Efficacy and tolerability of donepezil in vascular dementia. Positive results of a 24 week, multicenter, international, randomized placebo-controlled clinical trial. Stroke 2003; 34: 2323 – 32.
- 13.
Aarsland D, Hutchinson M, Larsen JP. Cognitive, psychiatric and motor response to galantamine in Parkinson’s disease with dementia. Int J Geriatr Psychiatry 2003; 18: 937 – 41.